Foliglurax Uses, Dosage, Side Effects and more
Foliglurax is under investigation in clinical trial NCT02639221 (A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects).
| Trade Name | Foliglurax |
| Generic | Foliglurax |
| Foliglurax Other Names | Foliglurax |
| Type | |
| Formula | C23H23N3O3S |
| Weight | Average: 421.52 Monoisotopic: 421.146012787 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
